info

Monday, 11 March 2019

Chronic Pain and the Use of Palmitoylethanolamide


                              http://austinpublishinggroup.com/neurological-disorders-epilepsy/


PEAis a natural occurring lipid belonging to the class of autacoids, we could characterize these molecules as tissue hormones. Autacoids such as PEA may become a new cornerstone in the treatment of chronic pain and inflammation. PEA is not a registered drug, but it is widely available as supplement. I use PEA in my patients suffering from neuropathic pain since 2010, and have done quite some research on it. In the many hundreds of patients I treated, dose-limiting and serious adverse events did not occur. This probably is related to the fact that PEA is an endogenous lipid, produced on demand in the membranes of our cells, and easily metabolized in the cell into metabolites which are than recycled in those membranes. It also implies that dose-reduction in case of liver- or kidney-insufficiency is not required. As more and more patients and doctors become aware of this natural compound, a short introduction might serve both groups.

Theuse of PEA as a painkiller in the first decade of this century was limited to Italy and Spain only, because clinical papers in the English language were missing. In Italy, the compound was used widely by neurologists and pain specialists, due to the work of the Italian Nobel laureate professor Rita Levi-Montalcini, who first clarified its mechanism of action as an Anti-Inflammatory Agent.


No comments:

Post a Comment

An Evaluation of the Role of fMRI in Patients with Lower Urinary Tract Dysfunction

                                                 https://www.austinpublishinggroup.com/urology/ Patientswith Lower Urinary Tr...